NCT02355197View on ClinicalTrials.gov

Antioxidants in Gestational Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Gestational Diabetes Mellitus
Interventions
DRUG

L-ascorbic acid

1 gram L-ascorbic acid (vitamin C …..) per day from the time of diagnosis until the time of delivery

Trial Locations (1)

12151

Kasr Alainy medical school, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02355197 - Antioxidants in Gestational Diabetes | Biotech Hunter | Biotech Hunter